Search

everythinglearnresearchcommunity

for

Search:↓

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

A woman had severe reactions to methotrexate, including skin issues and organ problems, but improved after 38 days in the hospital.

Kang'ai injection with FLO chemotherapy improves effectiveness and quality of life in advanced gastric cancer patients.

Erlotinib can cause excessive eyelash growth.

Fenoterol treatment causes increased hair growth due to higher metabolism in hair follicles, not hormones.

Tofacitinib may effectively treat folliculitis decalvans.

Targeted anticancer therapies often cause skin issues, affecting treatment adherence and quality of life.

Many drugs, not just chemotherapy, can cause reversible hair loss.

Vismodegib effectively treats advanced basal cell carcinoma but requires careful management of serious side effects.

CDK4/6 inhibitors generally maintain quality of life in metastatic breast cancer patients, except for some side effects like diarrhea and hair loss.

Selaginella doederleinii extract shows potential for cervical cancer treatment but needs more research.

The document concludes that low-dose acne treatment is most suitable for moderate acne, with high patient satisfaction and low relapse rates.

AHCC reduces hair loss and liver injury caused by chemotherapy in rodents.

Image analysis can effectively identify changes in scalps affected by chemotherapy-induced hair loss.

A boy with chromosome 13q deletion syndrome developed eye cancer, a woman with breast cancer lost vision due to a rare side-effect of her treatment, a man's vision worsened after using a hair loss drug, and two rare disorders were discussed. Optical Coherence Tomography is useful for diagnosing and monitoring these conditions.

Breast cancer patients should balance treatment with safe wellness practices to improve quality of life, consulting their oncologist first.

Permanent hair loss from chemotherapy significantly impacts patients' mental health and social life, highlighting the need for better patient education and support.

Topical finasteride with EGCG or TA improves drug release and dermal uptake, potentially treating hair loss effectively.

Cyproterone acetate and ethinylestradiol effectively reduce hirsutism and acne in women.

The combination treatment reduced prostate size and improved testosterone deficiency symptoms but was less effective for sexual function.

Cinnamon bark extract may help prevent weight loss and hair loss in breast cancer patients during chemotherapy and is safe to use.

Methotrexate reduced the need for steroids in asthma patients without worsening their condition.

Dermatological treatments can have significant side effects, including allergic reactions, sexual dysfunction, and increased cancer risk.

Temozolomide improves survival in grade III glioma patients without harming quality of life.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Chemotherapy can cause skin problems like hair loss, mouth sores, and skin darkening, and recognizing these can affect treatment decisions.

TCDD changes skin cell growth and keratin production in mice.

Some existing medicines show promise as safe treatments to protect against the side effects of radiation therapy.